Application 076962
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BROMOCRIPTINE MESYLATE | BROMOCRIPTINE MESYLATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-2042 | Bromocriptine Mesylate | bromocriptine mesylate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-2042 | Bromocriptine Mesylate | bromocriptine mesylate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-2042 | Bromocriptine Mesylate | bromocriptine mesylate | Mylan Pharmaceuticals Inc | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 31179 | ORIG | 2004-09-29 |